About this episode

The episode reviews recent advancements and datasets in localized HR-positive breast cancer treatment.

Featuring perspectives from Dr Harold J Burstein and Dr Joyce O’Shaughnessy, including the following topics: Introduction: ODAC — April 30, 2026 (00:00) Adjuvant CDK4/6 Inhibitors (13:03) Adjuvant Oral Selective Estrogen Receptor Degraders (21:53) Premenopausal Patients (30:52) Duration of Adjuvant Endocrine Treatment (38:44) Genomic Predictors of Chemotherapy Benefit (47:19) Neoadjuvant Treatment (55:13) CME information and select publications

People in this episode

Host: Dr. Neil Love

Guests: Dr Harold J Burstein, Dr Joyce O’Shaughnessy

Topics covered

• HR-Positive Breast Cancer
• Adjuvant Treatment
• CDK4/6 Inhibitors
• Selective Estrogen Receptor Degraders
• Genomic Predictors
• Neoadjuvant Treatment

Keywords

• breast cancer
• adjuvant therapy
• CDK4/6 inhibitors
• endocrine treatment
• genomic predictors
• neoadjuvant treatment

More episodes of Oncology Today with Dr Neil Love

• Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 20, 2026 · 1h 30m
• HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy · July 17, 2026 · 46 min
• For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress · July 16, 2026 · 1h 58m
• Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 15, 2026 · 2h 1m
• HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review · July 14, 2026 · 28 min
• Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer · July 12, 2026 · 15 min

Explore listener stats, chart rankings, contacts and more on the Oncology Today with Dr Neil Love podcast page.